WebHome Infusion Administration . Hospital Administration . Infusion Center Administration . Outpatient Facility Administration* [*Prior authorization required – see section (1)] HCPCS. Cytogam®: J0850 per 50 ml vial (2500 mg) Cytogam®: 90291 per dose . Privigen®: J1459 . per 500 mg . Asceniv. TM: J1554. per 500 mg. Bivigam ®: J1556 . per ... WebThis medication is administered by infusion into a vein by a health care professional. The first dose is given within 3 days of the transplant with additional doses at 2 to 4 week intervals. Side Effects Nausea, backache or flushing may occur during the infusion. Muscle stiffness, pain and tenderness may occur at the site of injection.
CytoGam Intravenous: Uses, Side Effects, Interactions, Pictures
WebCytoGam. STN: 103189. Proper Name: Cytomegalovirus Immune Globulin Intravenous (Human) Tradename: CytoGam. Manufacturer: Saol Therapeutics Inc. Indication: … WebEnsure the patient is not volume depleted prior to Cytogam® infusion. Visually inspect solution for particulate matter and discoloration. Do not use if solution is not colorless, free of ... Time Rate Initial (Start @) 15 mg/kg/h @ Start + 30 min. 30 mg/kg/h @ Start + 60 min. Max. 60 mg/kg/h (Do NOT exceed 75 mL/h) Subsequent doses : ... iphis pho
Cytogam (cytomegalovirus immune globulin intravenous …
WebInitial Infusion rate . Maintenance Infusion rate : Intravenous Administration . PI : 300 to 600 mg/kg every 3 to 4 weeks based on clinical response. 0.5 mL/kg/hr Weblin A and immunoglobulin M. Clinical studies show a marked decrease in the development of cytomegalovirus when transplant recipients are treated with CytoGam. CytoGam also has undergone trial testing for use in decreasing the instance of cytomegalovirus in patients with human immune deficiency virus (HIV). CytoGam therapy may continue for several … WebOct 13, 2024 · CYTOGAM should be stored between 2-8°C (36-46°F), and used within 6 hours after entering the vial. REFERENCES Snydman DR, McIver J, Leszczynski J, et al. A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipients. Transplantation 1984;38:553-557. Horowitz B, Wiebe ME ... iphis en ianthe